Aurobindo Pharma Ltd - Stock Price

  • BSE : 524804
  • ISIN CODE : INE406A01037
  • Industry : Pharmaceuticals & Drugs
  • House : Aurobindo
Aurobindo Pharma Ltd is not traded on BSE/NSE
+2.25 %+11.05
+2.38 %+11.65

Balance Sheet

Parameter MAR 19  MAR 18  YoY %Change
Share Capital585.90585.900.00
    Equity - Authorised660.00660.000.00
    Equity - Issued585.90585.900.00
    Equity Paid Up585.90585.900.00
    Equity Shares Forfeited0.000.000.00
    Adjustments to Equity0.000.000.00
    Preference Capital Paid Up0.000.000.00
    Face Value1.001.000.00
Share Warrants & Outstandings0.600.70-14.29
Total Reserves138321.30116217.6019.02
    Securities Premium4176.404175.700.02
    Capital Reserves920.00818.9012.35
    Profit & Loss Account Balance124161.50102117.6021.59
    General Reserves8131.608131.600.00
    Other Reserves931.80973.80-4.31
Reserve excluding Revaluation Reserve138321.30116217.6019.02
Revaluation reserve0.000.000.00
Shareholder's Funds138907.80116804.2018.92
Minority Interest15.9018.20-12.64
Long-Term Borrowings0.000.000.00
Secured Loans1799.504512.00-60.12
    Non Convertible Debentures0.000.000.00
    Converible Debentures & Bonds0.000.000.00
    Packing Credit - Bank0.000.000.00
    Inter Corporate & Security Deposit0.000.000.00
    Term Loans - Banks1310.704242.40-69.10
    Term Loans - Institutions0.000.000.00
    Other Secured488.80269.6081.31
Unsecured Loans0.000.000.00
    Fixed Deposits - Public0.000.000.00
    Loans and advances from subsidiaries0.000.000.00
    Inter Corporate Deposits (Unsecured)
    Foreign Currency Convertible Notes0.000.000.00
    Long Term Loan in Foreign Currency0.000.000.00
    Loans - Banks0.000.000.00
    Loans - Govt.
    Loans - Others0.000.000.00
    Other Unsecured Loan0.000.000.00
Deferred Tax Assets / Liabilities980.20764.8028.16
    Deferred Tax Assets6129.005391.7013.67
    Deferred Tax Liability7109.206156.5015.47
Other Long Term Liabilities113.00105.706.91
Long Term Trade Payables0.000.000.00
Long Term Provisions465.40558.60-16.68
Total Non-Current Liabilities3358.105941.10-43.48
Current LiabilitiesNANANA
Trade Payables26771.3023729.0012.82
    Sundry Creditors26771.3023729.0012.82
    Due to Subsidiaries- Trade Payables0.000.000.00
Other Current Liabilities25454.1019674.2029.38
    Bank Overdraft / Short term credit0.000.000.00
    Advances received from customers1671.00671.70148.77
    Interest Accrued But Not Due3.9011.10-64.86
    Share Application Money0.000.000.00
    Current maturity of Debentures & Bonds0.000.000.00
    Current maturity - Others0.000.000.00
    Other Liabilities23779.2018991.4025.21
Short Term Borrowings65732.1040313.4063.05
    Secured ST Loans repayable on Demands15040.703270.50359.89
    Working Capital Loans- Sec14883.503191.80366.30
    Buyers Credits - Unsec0.000.000.00
    Commercial Borrowings- Unsec0.000.000.00
    Other Unsecured Loans35807.9033851.105.78
Short Term Provisions2471.502942.30-16.00
    Proposed Equity Dividend0.000.000.00
    Provision for Corporate Dividend Tax0.000.000.00
    Provision for Tax662.70969.50-31.65
    Provision for post retirement benefits0.000.000.00
    Preference Dividend0.000.000.00
    Other Provisions1808.801972.80-8.31
Total Current Liabilities120429.0086658.9038.97
Total Liabilities262710.80209422.4025.45
Gross Block104976.2078947.8032.97
Less: Accumulated Depreciation20227.7013741.0047.21
Less: Impairment of Assets0.000.000.00
Net Block84748.5065206.8029.97
Lease Adjustment A/c0.000.000.00
Capital Work in Progress13419.4013995.40-4.12
Non Current Investments3602.003115.2015.63
Long Term Investment3602.003115.2015.63
Long Term Loans & Advances3644.402619.1039.15
Other Non Current Assets386.20869.30-55.57
Total Non-Current Assets109065.7087640.8024.45
Current Assets Loans & AdvancesNANANA
Currents Investments0.200.200.00
    Raw Materials23967.1022071.408.59
    Work-in Progress13549.9010794.7025.52
    Finished Goods17016.2012027.1041.48
    Packing Materials3365.502805.1019.98
    Stores  and Spare1674.501429.0017.18
    Other Inventory12882.809456.8036.23
Sundry Debtors34137.8030802.0010.83
    Debtors more than Six months0.000.000.00
    Debtors Others34950.8031579.0010.68
Cash and Bank19571.8012622.5055.05
    Cash in hand3.403.303.03
    Balances at Bank19285.7012427.3055.19
    Other cash and bank balances282.70191.9047.32
Other Current Assets19198.2012233.2056.94
    Interest accrued on Investments38.1033.4014.07
    Interest accrued on Debentures0.000.000.00
    Deposits with Government0.000.000.00
    Interest accrued and or due on loans8.200.000.00
    Prepaid Expenses0.000.000.00
    Other current_assets19151.9012199.8056.99
Short Term Loans and Advances8281.107539.609.83
    Advances recoverable in cash or in kind2265.502606.20-13.07
    Advance income tax and TDS345.60645.50-46.46
    Amounts due from directors0.000.000.00
    Due From Subsidiaries0.000.000.00
    Inter corporate deposits0.000.000.00
    Corporate Deposits0.000.000.00
    Other Loans & Advances5670.004287.9032.23
Total Current Assets153645.10121781.6026.16
Net Current Assets (Including Current Investments)33216.1035122.70-5.43
Miscellaneous Expenses not written off0.000.000.00
Total Assets262710.80209422.4025.45
Contingent Liabilities1337.102117.90-36.87
Total Debt69667.6047699.3046.06
Book Value237.08199.3618.92
Adjusted Book Value237.08199.3618.92

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. was incorporated in the year 26-12-1986. Its today's share price is 501.05. Its current market capitalisation stands at Rs 29358.45 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes B Adi Reddy, Savita Mahajan, Avnit Bimal Singh, M Sitarama Murty, PV Ramprasad Reddy, P Sarath Chandra Reddy, M Madan Mohan Reddy, M Sivakumaran, N Govindarajan, K Nithyananda Reddy, K Ragunathan.

It is listed on the BSE with a BSE Code of 524804 , NSE with an NSE Symbol of AUROPHARMA and ISIN of INE406A01037. It's Registered office is at Plot No. 2,Maitrivihar ,AmeerpetHyderabad-500038, Telangana. Their Registrars are ACC Ltd. It's auditors are BSR & Associates LLP, K Nagaraju & Associates, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co

Latest News